Medtronic plc (MDT)

Market Cap	114.17B
Revenue (ttm)	32.32B
Net Income (ttm)	4.20B
Shares Out	1.33B
EPS (ttm)	3.14
PE Ratio	27.36
Forward PE	16.14
Dividend	$2.76 (3.21%)
Ex-Dividend Date	Mar 21, 2024

Volume	4,749,951
Open	85.83
Previous Close	85.64
Day's Range	85.10 - 86.17
52-Week Range	68.84 - 91.00
Beta	0.80
Analysts	Buy
Price Target	95.33 (+10.95%)
Earnings Date	May 23, 2024

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1949
• Employees: 95,000
• Stock Exchange: NYSE
• Ticker Symbol: MDT

Financial Performance

In 2023, Medtronic's revenue was $31.23 billion, a decrease of -1.45% compared to the previous year's $31.69 billion. Earnings were $3.76 billion, a decrease of -25.42%.

Analyst Forecast

According to 12 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is $95.33, which is an increase of 10.95% from the latest price.

Price Target

$95.33

(10.95% upside)

Analyst Consensus: Buy